Author:
González-Olmo Maria Jose,Diego Rafael Gómez de,Delgado-Ramos Bendición,Romero-Maroto Martin,Carrillo-Diaz María
Abstract
The aim of this study was to analyze the evolution of germ aversion, to perceived infectability and to the fear of COVID-19 from the beginning of the pandemic until the arrival of the vaccines. A repeated measures design was used with three time points during the pandemic. The survey consisted of: Scale of perceived vulnerability to disease; Scale of fear of COVID-19; They were asked if they were vaccinated and if that vaccination is complete. They were asked if they would avoid the dental clinic through fear of COVID-19; and if they have reduced preventive practice in response to COVID-19. A T0-T1 increase in perceived infectability and germ aversion was reported. However, fear of COVID-19 decreased at T1-T2. The vaccinated experienced a greater reduction than the unvaccinated and a greater relaxation of their preventive practice. The frequency of dental avoidance decreased in the vaccinated group from T1 to T2 by 68.3% while in the non-vaccinated this reduction was only 4.9%; X2 = 18.58 (p < 0.01). In summary, vaccination has had an impact in the reduction of perceived infectability and in reducing fear of COVID-19. Nevertheless, germ aversion has remained stable and independent of vaccination. Empirical support is found for the affirmation that vaccination can reduce certain preventive behavior and dental avoidance.
Subject
Public Health, Environmental and Occupational Health
Reference32 articles.
1. The COVID-19 pandemic: a comprehensive review of taxonomy, genetics, epidemiology, diagnosis, treatment, and control;Helmy;J Clin Med.,2020
2. WHO declares COVID-19 a pandemic;Cucinotta;Acta Bio Med Atenei Parm.,2020
3. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations;Phua;Lancet Res Med.,2020
4. The socio-economic implications of the coronavirus pandemic (COVID-19): a review;Nicola;Int J Surg.,2020
5. Use of facemasks during the COVID-19 pandemic;Schünemann;Lancet Respir Med.,2020